INVENTIVA (EPA:IVA) | WebDisclosure

BRIEF

published on 10/23/2024 at 11:36, 1 year 3 months ago

Franchissement de seuils par BVF Partners dans le capital d'Inventiva

Droits De Vote Augmentation De Capital Franchissement De Seuils Inventiva BVF Partners
BRIEF

published on 10/23/2024 at 11:36, 1 year 3 months ago

BVF Partners Crosses Thresholds in Inventiva's Capital

Voting Rights Capital Increase Crossing Thresholds Inventiva BVF Partners
PRESS RELEASE

published on 10/23/2024 at 11:33, 1 year 3 months ago

Franchissement de seuils
Déclaration de franchissement de seuils par Invus Public Equities, LP. concernant Inventiva, suite à une augmentation de capital

Augmentation De Capital Franchissement De Seuils Inventiva Invus Public Equities
PRESS RELEASE

published on 10/23/2024 at 11:31, 1 year 3 months ago

Franchissement de seuils
Déclaration de franchissement de seuils par BVF Partners LP pour le compte de fonds associés à INVENTIVA sur Euronext Paris

Euronext Paris Déclaration Franchissement De Seuils Inventiva BVF Partners LP
BRIEF

published on 10/21/2024 at 14:35, 1 year 3 months ago

Inventiva présente un abstract au Liver Meeting™ 2024

Essai Clinique Inventiva NASH Lanifibranor Liver Meeting™
BRIEF

published on 10/21/2024 at 14:35, 1 year 3 months ago

Inventiva presents an abstract at the Liver Meeting™ 2024

Clinical Trial Inventiva NASH Lanifibranor Liver Meeting™
PRESS RELEASE

published on 10/21/2024 at 14:30, 1 year 3 months ago

Inventiva annonce un abstract « late breaker » sur l’essai clinique de Phase 2, LEGEND, combinant lanifibranor et empagliflozine, lors du Liver Meeting™ 2024 organisé par l’AASLD
Inventiva annonce un abstract "late breaker" sur l'essai clinique de Phase 2, LEGEND, combinant lanifibranor et empagliflozine lors du Liver Meeting™ 2024 organisé par l'AASLD

Essai Clinique Inventiva Lanifibranor Abstract Empagliflozine
PRESS RELEASE

published on 10/21/2024 at 14:30, 1 year 3 months ago

Inventiva announces a late breaker abstract from LEGEND, Phase 2 trial, evaluating lanifibranor in combination with empagliflozin in MASH at the AASLD The Liver Meeting® 2024
Inventiva announces late breaker abstract from LEGEND Phase 2 trial evaluating lanifibranor with empagliflozin in MASH at AASLD The Liver Meeting® 2024

Inventiva MASH Lanifibranor LEGEND Phase 2 Empagliflozin
BRIEF

published on 10/14/2024 at 19:50, 1 year 3 months ago

Inventiva obtient l'approbation de l'AMF pour son prospectus de financement

AMF Financement Médicaments Inventiva Stéatohépatite
BRIEF

published on 10/14/2024 at 19:50, 1 year 3 months ago

Inventiva obtains AMF approval for its financing prospectus

AMF Funding Inventiva Steatohepatitis Drugs

Published on 01/31/2026 at 03:15, 1 day 1 hour ago

Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 02:20, 1 day 2 hours ago

Boron One Announces First Closing of Financing
Published on 01/31/2026 at 01:40, 1 day 3 hours ago

Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/31/2026 at 00:00, 1 day 5 hours ago

BE Resources Announces Private Placement
Published on 01/30/2026 at 23:00, 1 day 6 hours ago

Avidian Gold Corp. Announces Director Resignation

View all ACCESSWIRE

Published on 01/31/2026 at 15:54, 13 hours 10 minutes ago

EQS-Adhoc: Wolford AG: Capital increase will not be implemented
Published on 01/31/2026 at 12:25, 16 hours 40 minutes ago

JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/31/2026 at 02:45, 1 day 2 hours ago

CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 1 day 7 hours ago

Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 20:10, 1 day 8 hours ago

Cynosure Lutronic Announces Completion of EU MDR Approval and Global Momentum for Mosaic 3D™ Ahead of IMCAS 2026

View all EQS

Published on 01/30/2026 at 18:40, 1 day 10 hours ago

ICADE - Bilan semestriel du contrat de liquidite
Published on 01/30/2026 at 18:01, 1 day 11 hours ago

Emova Group - Résultats annuels 2024/25
Published on 01/30/2026 at 17:45, 1 day 11 hours ago

Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 17:45, 1 day 11 hours ago

Schneider Electric lance une augmentation de capital réservée aux salariés
Published on 01/30/2026 at 08:30, 1 day 20 hours ago

Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés

View all LES ECHOS COMFI WIRE

News